These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4738316)

  • 21. Antiserum to a soluble lymphoid membrane preparation stimulates human leukocyte DNA synthesis.
    Einstein AB; Mann DL; Ficker S; Terry WD
    J Immunol; 1971 Oct; 107(4):1205-8. PubMed ID: 5129731
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of soluble cytotoxins in cell-mediated immunity.
    Walker SM; Lucas ZJ
    Transplant Proc; 1973 Mar; 5(1):137-40. PubMed ID: 4572090
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics of a cytotoxin ("lymphotoxin") produced by stimulation of human lymphoid tissue.
    Peter JB; Stratton JA; Stempel KE; Yu D; Cardin C
    J Immunol; 1973 Sep; 111(3):770-82. PubMed ID: 4741296
    [No Abstract]   [Full Text] [Related]  

  • 24. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphocyte cytotoxicity: technical aspects. Introduction.
    Perlmann P
    Transplant Proc; 1972 Sep; 4(3):295-8. PubMed ID: 5080601
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 27. A sensitive microassay system for lymphocyte-mediated cytotoxicity induced by PHA and PPD.
    Amino N; Degroot LJ
    J Immunol; 1973 Aug; 111(2):464-71. PubMed ID: 4717990
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible inhibition of lymphocyte-mediated cytotoxicity by cytochalasin B.
    Cerottini JC; Brunner KT
    Nat New Biol; 1972 Jun; 237(78):272-3. PubMed ID: 4504462
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells.
    Möller G; Svehag SE
    Cell Immunol; 1972 May; 4(1):1-19. PubMed ID: 4552747
    [No Abstract]   [Full Text] [Related]  

  • 30. Ia and H-2 antigens on blast cells.
    Hauptfeld M; Hauptfeld V; Klein J
    Transplantation; 1975 Jun; 19(6):528-30. PubMed ID: 124489
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
    Yust I; Wunderlich JR; Mann DL; Buell DN
    J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocytes, anti-tumour agents, and target cells.
    Kadaghidze ZG; Chernyakhovskaya IY; Rimalis RT; Svet-Moldavsky GJ
    Lancet; 1969 Sep; 2(7622):698. PubMed ID: 4185441
    [No Abstract]   [Full Text] [Related]  

  • 33. Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).
    Sherwood G; Blaese RM
    Clin Exp Immunol; 1973 Apr; 13(4):515-20. PubMed ID: 4736825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the role of antibody in the cytotoxic action of lymph cells on xenogeneic target cells.
    Grant CK; Avis PJ; Hall JG; Alexander P
    Transplantation; 1971 Mar; 11(3):356-8. PubMed ID: 5558568
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple effector roles of lymphocytes in allograft immunity.
    Grant CK; Evans R; Alexander P
    Cell Immunol; 1973 Jul; 8(1):136-46. PubMed ID: 4542361
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytotoxic potential of mouse spleen cells on H-2 antibody-treated target cells.
    Kiessling R; Klein E
    J Exp Med; 1973 Feb; 137(2):527-32. PubMed ID: 4631140
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphocyte classes in New Zealand mice. I. Ontogeny and mitogen responsiveness of thymocytes and thymus-derived lymphocytes.
    Stobo JD; Talal N; Paul WE
    J Immunol; 1972 Oct; 109(4):692-700. PubMed ID: 4116356
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunocompetent cells in man. II. Existence of distinct populations of circulating lymphocytes capable of responding to stimulation by phytohemagglutinin, antigen, antilymphocyte serum and allogeneic lymphocytes.
    Wu AS; Algom D; Richter M
    Pathol Microbiol (Basel); 1974; 41(1):1-10. PubMed ID: 4278134
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro stimulation of mouse thymus cells by PHA and allogeneic cells.
    Blomgren H; Svedmyr E
    Cell Immunol; 1971 Aug; 2(4):285-99. PubMed ID: 5127823
    [No Abstract]   [Full Text] [Related]  

  • 40. Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes.
    Golstein P; Erik MD; Svedmyr AJ; Wigzell H
    J Exp Med; 1971 Dec; 134(6):1385-402. PubMed ID: 5001703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.